University Of Arkansas

This study tests whether two bispecific antibodies (teclistamab and talquetamab) given in sequence can improve survival in 50 people with high-risk multiple myeloma. Participants receive chemotherapy, stem cell collection, and antibody treatments. Those with remaining cancer cell…

This study tests whether injecting the measles, mumps, and rubella (MMR) vaccine directly into pancreatic tumors can shrink them. About 20 adults with borderline resectable or unresectable pancreatic cancer will receive the injection. Researchers will check for immune cell change…

This study tests whether an artificial intelligence (AI) algorithm can help doctors find more aggressive prostate cancers during biopsies. About 50 men with uncertain or low-risk MRI results will be randomly assigned to either an AI-guided biopsy or a standard biopsy. The goal is…

This study tests whether a small daily dose of naltrexone (3 mg) can reduce fatigue in men with prostate cancer who are receiving hormone therapy (ADT). The trial will enroll 60 participants and measure changes in tiredness, quality of life, and safety. It is a Phase 2 study, mea…

This study tests whether taking essential amino acid supplements for two weeks before and three months after spinal surgery helps adults aged 40-65 recover better. Participants will be randomly assigned to receive either the supplement or a placebo. The goal is to see if the supp…

This study will compare standard postpartum care to a program called CAREPATH, which adds three telehealth visits with a community health worker. About 500 new mothers will take part to see if the extra support helps them complete their postpartum checkup, catch complications ear…

This study tests whether training healthcare providers can improve how they help patients quit smoking and get screened for lung cancer. About 300 doctors who treat smokers will take online training modules and answer surveys. The goal is to see if the training changes their know…